TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
7.46
-0.14 (-1.84%)
Jun 4, 2026, 1:53 PM CST
TaiwanJ Pharmaceuticals Market Cap
TaiwanJ Pharmaceuticals has a market cap or net worth of 608.93 million as of June 4, 2026. Its market cap has decreased by -3.18% in one year.
Market Cap
608.93M
Enterprise Value
542.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.46
Market Cap Chart
Since October 21, 2015, TaiwanJ Pharmaceuticals's market cap has decreased from 2.26B to 608.93M, a decrease of -73.01%. That is a compound annual growth rate of -11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 608.93M | -1.43% |
| Dec 31, 2025 | 617.74M | -5.98% |
| Dec 31, 2024 | 657.00M | -40.71% |
| Dec 29, 2023 | 1.11B | 39.15% |
| Dec 30, 2022 | 796.29M | 4.93% |
| Dec 30, 2021 | 758.89M | -24.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.01B |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 969.24M |
| Taiwan Advance Bio-Pharmaceutical | 904.50M |
| NatureWise Biotech & Medicals | 895.40M |
| MegaPro Biomedical | 851.08M |
| Neith | 766.43M |
| BioLASCO Taiwan | 745.31M |